| Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi H Qadri, AH Shah, SM Ahmad, B Alshehri, A Almilaibary, MA Mir Saudi Journal of Biological Sciences 29 (9), 103376, 2022 | 64 | 2022 |
| Novel strategies to combat the emerging drug resistance in human pathogenic microbes H Qadri, AH Shah, M Mir Current drug targets 22 (12), 1424-1436, 2021 | 56 | 2021 |
| Integrons in the development of antimicrobial resistance: critical review and perspectives BA Bhat, RA Mir, H Qadri, R Dhiman, A Almilaibary, M Alkhanani, MA Mir Frontiers in Microbiology 14, 1231938, 2023 | 40 | 2023 |
| RETRACTED: Immunotherapies against human bacterial and fungal infectious diseases: A review H Qadri, AH Shah, M Alkhanani, A Almilaibary, MA Mir Frontiers in Medicine 10, 1135541, 2023 | 30 | 2023 |
| Glucose-The X factor for the survival of human fungal pathogens and disease progression in the host H Qadri, MF Qureshi, MA Mir, AH Shah Microbiological Research 247, 126725, 2021 | 20 | 2021 |
| Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance H Qadri, AH Shah, MA Mir, MF Qureshi, R Prasad Fungal Genetics and Biology 161, 103713, 2022 | 12 | 2022 |
| Bioactivities and chemoprofiling comparisons of Chenopodium ambrosioides L and Chenopodium botrys L. growing in Kashmir India SA Shameem, KZ Khan, AA Waza, AH Shah, H Qadri, BA Ganai Asian J. Pharm. Clin. Res 12 (1), 124-129, 2019 | 12 | 2019 |
| Human pathogenic microbes: Diseases and concerns MA Mir Academic Press, 2022 | 11 | 2022 |
| Physicochemical and anti-fungal studies of the pharmaceutical co-crystal/salt of fluconazole AA Ahangar, H Qadri, AA Malik, MA Mir, AH Shah, AA Dar Molecular pharmaceutics 20 (7), 3471-3483, 2023 | 9 | 2023 |
| Significance of immunotherapy for human bacterial diseases and antibacterial drug discovery MA Mir, S Qadri Journal: Human Pathogenic Microbes, 129-161, 2022 | 5 | 2022 |
| Role of immunogenetics polymorphisms in infectious diseases H Qadri, AH Shah, MA Mir A Molecular Approach to Immunogenetics, 169-191, 2022 | 5 | 2022 |
| Microbiota, natural products, and human health: exploring interactions for therapeutic insights H Qadri, AH Shah, A Almilaibary, MA Mir Frontiers in Cellular and Infection Microbiology 14, 1371312, 2024 | 4 | 2024 |
| Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies H Qadri, AA Malik, AA Ahangar, MA Mir, AA Dar, AH Shah RSC Pharmaceutics 1 (4), 705-715, 2024 | 2 | 2024 |
| Antifungal therapies and drug resistance H Qadri, MA Mir, AH Shah Human Fungal Diseases, 130-145, 2024 | 1 | 2024 |
| Dual Antifungal and Antiproliferative Activities of a Novel Protein Fraction from a Medicinally Important Herb Trillium govanianum Wall. ex. D. Don SS Wani, H Qadri, AH Shah, TA Dar Applied Biochemistry and Biotechnology 196 (8), 5080-5098, 2024 | | 2024 |
| Correction: Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies H Qadri, AA Malik, AA Ahangar, MA Mir, AA Dar, AH Shah RSC Pharmaceutics 1 (4), 854-854, 2024 | | 2024 |
